NEWS: GPC puts the PR spotlight on cancer and asthma

The World Cancer Research Fund is launching a pan-European PR and lobbying campaign to promote its findings on the link between diet and cancer.

The World Cancer Research Fund is launching a pan-European PR and

lobbying campaign to promote its findings on the link between diet and

cancer.



The charity has hired the public affairs company GPC Connect and its

European office GPC Market Access Europe in Brussels to manage the

programme.



The fund, part of the American Cancer Research Institute, has briefed

GPC to target civil servants and health ministers in a bid to get diet

linked with cancer in the annual progress report of the government’s

Health of the Nation target.



GPC’s PR partner Countrywide Communications has been appointed to get

global media coverage for the findings of the fund’s study, to be

released in May 1997.



GPC Connect has also been appointed by Glaxo Wellcome to run an

international lobbying drive to delay the ban on metered dose inhalers

(MDIs) as used by asthma sufferers. The Montreal Protocol, an

international agreement, banned CFC use by 1 January 1996 with the

exception of MDIs.



Glaxo Wellcome is hoping to delay an eventual ban on MDIs to allow it

time to develop alternatives. Rival 3M Pharmaceuticals has already

developed a non-CFC MDI.



GPC Connect’s campaign will aim to advise local operating companies how

to lobby their member states.



The combined fee income for both campaigns, which will run initially

until the end of the year, is around pounds 40,000.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in